Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Application Methods and Treatment Options 1
Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8
SEND ME ONE PREDICTION YOU HAVE FOR 2026 (2 PARAS OR LESS) AND ILL INCLUDE MY FAVORITE ONES IN NEXT WEEKS NEWSLETTER Below are my predictions for 2026
However, their usage should always be supervised by healthcare professionals due to potential side effects and interactions
Drug/Laboratory Test Interactions Persons taking most antibiotics, methotrexate, and pyrimethamine invalidate folic acid and vitamin B 12 diagnostic blood assays
US$ 21.23
US$ 21.25
US$ 21.55
US$ 23.31
US$ 21.91
US$ 29.65
US$ 28.06
US$ 23.76
